Cardinal Health (CAH) Stock Forecast & Price Target

Cardinal Health
Bear Case

Investors should be bearish about investing in Cardinal Health, Inc. for these reasons:

• Cardinal Health, Inc. reported a negative return on equity of 98.53% for the most recent quarter, which suggests that the company is not efficiently using its equity capital to generate profits, potentially indicating underlying financial inefficiencies or high leverage that could erode shareholder value.
• Insiders have sold a significant number of shares recently, with CEO Jason M. Hollar selling 80,000 shares and CEO Stephen M. Mason selling 35,000 shares in August 2026, which may signal that company executives are less confident in the stock's future performance or are seeking to diversify their personal holdings.
• The company's net margin is only 0.67%, which is relatively low for a healthcare distributor, indicating that a large portion of revenue is consumed by costs, leaving little room for error in pricing or cost management and potentially limiting the company's ability to invest in growth initiatives.
• Cardinal Health, Inc. has a P/E ratio of 34.12, which is higher than the average for the healthcare sector, suggesting that the stock may be overvalued relative to its earnings, and investors may be paying a premium for growth that may not be sustained in the future.
• Short interest in the stock has been relatively high, with 6,393,294 shares shorted as of August 14, 2026, representing 2.75% of the float, which indicates that some investors are betting against the stock and could potentially drive down the price if they cover their positions.